Kazis LE. Health outcome assessments in medicine: history, applications, and new directions. Adv Intern Med 1991; 36: 109–130.
Ellwood PM. Shattuck lecture—outcomes management. A technology of patient experience. N Engl J Med 1988; 318: 1549–1556.
Jonsson B. Assessment of quality of life in chronic diseases. Acta Paediatr Scand Suppl 1987; 337: 164–169.
Revicki DA. Health-related quality of life in the evaluation of medical therapy for chronic illness. J Family Pract 1989; 29: 377–380.
Cheatle MD. The effect of chronic orthopedic infection on quality-of-life. Orthop Clin N Am 1991; 22: 539–547.
Spilker B, Molinek FR Jr, Johnston KA, Simpson RL Jr, Tilson HH. Quality of life bibliography and indexes. Med Care 1990; 28: DS1–D77.
Spilker B, White WSA, Simpson RL Jr, Tilson HH. Quality of life bibliography and indexes, 1990 Update J Clin R Pharm 1992 6: 87–156.
Spilker B, Simpson RL Jr, Tilson HH, Quality of life bibliography and indexes, 1991 update, J Clin R Pharmacol 1992; 6: 205–266.
Berzon RA, Simeon GP, Simpson, RL Jr, Donnelly MA, Tilson HH, Quality of life bibliography and indexes: 1993 update, Qual Life Res 1995; 4: 53–73.
Berzon RA, Donnelly MA, Simpson RL Jr, Simeon GP, Tilson HH. Quality of life bibliography and indexes, 1994 update. Qual Life Res 1995; 4: 547–569.
Aaronson NK. Qualify of life assessment in clinical trials: methodologic issues. Control Clin Trials 1989; 10: 195S–208S.
Fletcher AE, Bulpitt CJ. Measurement of qualify of life in clinical trials of therapy. Cardiology 1988; 75Suppl 1: 41–52.
Wiklund I, Karlberg J. Evaluation of quality of life in clinical trials. Selecting quality-of-life measures. Control Clin Trials 1991; 12: 204S–216S.
Bergner M. Quality of life, health status, and clinical research. Med Care 1989; 27: S148.
McHorney CA, Ware JE, Rogers W, Raczek AE, Lu JF. The validity and relative precision of MOS short-and long-form health status scales and Dartmouth COOP charts. Results from the Medical Outcomes Study. Med Care 1992; 30: MS253.
Kirshner B, Guyatt G. A methodological framework for assessing health indices. J Chronic Dis 1985; 38: 27–36.
Guyatt GH, Veldhuyzen Van Zanten SJ, Feeny DH, Patrick DL. Measuring quality of life in clinical trials: a taxonomy and review. Can Med Assoc J 1989; 140: 1441–1448.
Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993; 118: 622–629.
Guyatt G, Walter S, Norman G. Measuring change over time: assessing the usefulness of evaluative instruments. J Chronic Dis 1987; 40: 171–178.
Guyatt GH, Deyo RA, Charlson M, Levine MN, Mitchell A. Responsiveness and validity in health status measurement: a clarification. J Clin Epidemiol 1989; 42: 403–408.
Guyatt GH, Kirshner B, Jaeschke R. A methodologic framework for health status measures: clarity or oversimplification? J Clin Epidemiol 1992; 45: 1353–1355.
Guyatt GH, Kirshner B, Jaeschke R. Measuring health status: what are the necessary measurement properties? J Clin Epidemiol 1992; 45: 1341–1345.
Hays RD, Hadorn D. Responsiveness to change: an aspect of validity, not a separate dimension. Qual Life Res 1992; 1: 73–75.
Norman GR. Issues in the use of change scores in randomized trials. J Clin Epidemiol 1989; 42: 1097–1105.
Williams JI, Naylor CD. Procrustean frameworks. J Clin Epidemiol 1993; 46: 111–112.
Williams JI, Naylor CD. How should health status measures be assessed? Cautionary notes on procrustean frameworks. J Clin Epidemiol 1992; 45: 1347–1351.
Deyo RA. Measuring functional outcomes in therapeutic trials for chronic disease. Control Clin Trials 1984; 5: 223–240.
Kazis LE, Anderson JJ, Meenan RF. Effect sizes for interpreting changes in health status. Med Care 1989; 27: S178–S189.
Liang MH, Fossel AH, Larson MG. Comparisons of five health status instruments for orthopedic evaluation. Med Care 1990; 28: 632–642.
Katz JN, Larson MG, Phillips CB, Fossel AH, Liang MH. Comparative measurement sensitivity of short and longer health status instruments. Med Care 1992; 30: 917–925.
Henry DA, Wilson A. Meta-analysis Part 1: an assessment of its aims, validity and reliability. Med J Aust 1992; 156: 31–38.
Chouinard MJ, Braun CMJ. A meta-analysis of the relative sensitivity of neuropsychological screening tests. J Clin Exp Neuropsychol 1993; 15: 591–607.
Beto JA, Banal V. Quality of life in treatment of hypertension. A meta-analysis of clinical trials. Am J Hypertonias 1992; 5: 125–133.
Workman PM, Eaton WH. Cumulating quality of life results in controlled clinical trials of coronary artery bypass graft surgery. Control Clin Trials 1985; 6: 289–305.
Veldhuyzen Van Zanten SJ. Quality of life as outcome measures in randomized clinical trials. An overview of three general medical journals. Control Clin Trials 1991; 12: 234S–242S.
Hollandsworth JG, Jr. Evaluating the impact of medical treatment on the quality of life: a 5–year update. Soc Sci Med 1988; 26: 425–434.
Hunter JE, Schmidt FL. Methods of Meta-Analysis. Newbury Park, CA: Sage Publications, 1990.
Canadian Erythropoietin Study Group. Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. BMJ 1990; 300: 573. (Erythropoietin in haemodialysis.)
Andrykowski MA, Henslee PJ, Barnett RL. Longitudinal assessment of psychosocial functioning of adult survivors of allogeneic bone marrow transplantation. Bone Marrow Transplant 1989; 4: 505. (Bone marrow transplant.)
Bombardier C, Raboud J. A comparison of health-related quality-of-life measures for rheumatoid arthritis research. The Auranofin Cooperating Group. Control Clin Trials 1991; 12: 243S. (Auranofin in rheumatoid arthritis.)
Bombardier C, Ware J, Russell IJ. Auranofin therapy and quality of life in patients with rheumatoid arthritis. Am J Med 1986; 81: 565. (Auranofin in rheumatiod arthritis.)
Bombardier C, Ware J, Russell IJ, Larson M, Chalmers A, Read JL. Auranofin therapy and quality of life in patients with rheumatoid arthritis. Results of a multicenter trial. Am J Med 1986; 81: 565. (Auranofin in rheumatoid arthritis.)
Borgquist L, Nilsson LT, Lindelow G, Wiklund I, Thorngren KG. Perceived health in hip-fracture patients: a prospective follow-up of 100 patients. Age Ageing 1992; 21: 109. (Recovery from hip fracture.)
Calfas KJ, Kaplan RM, Ingram RE. One-year evaluation of cognitive-behavioral intervention in osteoarthritis. Arthritis Care Res 1992; 5: 202. (Counseling in osteoarthritis.)
Cunningham AJ, Lockwood GA, Cunningham JA. A relationship between perceived self-efficacy and quality of life in cancer patients. Patient Educat Counsel 1991; 17: 71. (Teaching coping skills.)
Cunningham AJ, Lockwood GA, Edmonds CV. Which cancer patients benefit most from a brief, group, coping skills program? Int J Psychiatr Med 1993; 23: 383. (Teaching coping skills.)
Evans RW, Rader B, Manninen DL. The quality of life of hemodialysis recipients treated with recombinant human erythropoietin. Cooperative Multicenter EPO Clinical Trial Group. JAMA 1990; 263: 825. (Erythropoietin in haemodialysis.)
Fitzpatrick R, Newman S, Lamb R, Shipley M. A comparison of measures of health status in rheumatoid arthritis. Br J Rheumatol 1989; 28: 201. (Progression of rheumatoid arthritis.)
Fitzpatrick R, Ziebland S, Jenkinson C, Mowat A. The social dimension of health status measures in rheumatoid arthritis. Int Disability Studies 1991; 13: 34. (Progression of rheumatoid arthritis.)
Fitzpatrick R, Ziebland S, Jenkinson C, Mowat A. A comparison of the sensitivity to change of several health status instruments in rheumatoid arthritis. J Rheumatol 1993; 20: 429. (Progression of rheumatoid arthritis.)
Fries JF, Spitz PW, Young DY. The dimensions of health outcomes: The Health Assessment Questionnaire, Disability and Pain Scales. J Rheumatol 1982; 9(5): 789. (Progression of rheumatoid arthritis.)
Hassan SJ, Weymuller EAJ. Assessment of quality of life in head and neck cancer patients. Head Neck 1993; 15: 485. (Progression of tumour.)
Hawley DJ, Wolfe F. Sensitivity to change of the Health Assessment Questionnaire (HAQ) and other clinical and health status measures in rheumatoid arthritis: results of short-term clinical trials and observational studies versus long-term observational studies. Arthritis Care Res 1992; 5: 130. (Progression versus multiple treatment for rheumatoid arthritis.)
Hidding A, van der Linden S, Boers M et al. Is group physical therapy superior to individualized therapy in ankylosing spondylitis? A randomized controlled trial. Arthritis Care Res 1993; 6: 117. (Group versus individual physical therapy.)
Hoffman LA, Wesmiller SW, Sciurba FC et al. Nasal cannula and transtracheal oxygen delivery. A comparison of patient response after 6 months of each technique. Am Rev Respirat Dis 1992; 145: 827. (Alternative oxygen delivery systems.)
Jenkinson C, Ziebland S, Fitzpatrick R, Mowat A. Sensitivity to change of weighted and un-weighted versions of two health status measures. Int J Health Sci 1991; 2: 189. (Observational study.)
Jones PW. Quality of life, symptoms and pulmonary function in asthma: long-term treatment with nedocromil sodium examined in a controlled multicentre trial. Nedocromil Sodium Quality of Life Study Group. Eur Respirat J 1994; 7: 55. (Nedocromil in asthma.)
Kaplan RM, Anderson JP, Wu AW, Mathews WC, Kozin F, Orenstein D. The Quality of Well-being Scale. Applications in AIDS, cystic fibrosis, and arthritis. Med Care 1989; 27: S27. (AZT in acquired immune deficiency syndrome (AIDS) and non-steroidal anti-inflammatory drugs (NSAIDS) in rheumatoid arthritis.)
Katz JN, Larson MG, Phillips CB, Fossel AH, Liang MH. Comparative measurement sensitivity of short and longer health status instruments. Med Care 1992; 30: 917. (Hip replacement.)
Kazis LE, Callahan LF, Meenan RF, Pincus T. Health status reports in the care of patients with rheumatoid arthritis. J Clin Epidemiol 1990; 43: 1243. (NSAIDS in rheumatoid arthritis.)
Larson JL, Kim MJ, Sharp JT, Larson DA. Inspiratory muscle training with a pressure threshold breathing device in patients with chronic obstructive pulmonary disease. Am Rev Respirat Dis 1988; 138: 689. (Breathing exercise in chronic obstructive pulmonary disease (COPD).)
Laupacis A, Bourne R, Rorabeck C et al. The effect of elective total hip replacement on health-related quality of life. J Bone Joint Surg Am 1993; 75: 1619. (Hip replacement.)
Laupacis A, Muirhead N, Keown P, Wong C. A disease-specific questionnaire for assessing quality of life in patients on hemodialysis. Nephron 1992; 60: 302. (Disease progression during haemodialysis.)
Laupacis A, Pus N, Muirhead N, Wong C, Ferguson B, Keown P. Disease-specific questionnaire for patients with a renal transplant. Nephron 1993; 64: 226. (Renal transplant.)
Laupacis A, Wong C, Churchill D. The use of generic and specific quality-of-life measures in hemodialysis patients treated with erythropoietin. The Canadian Erythropoietin Study Group. Control Clin Trials 1991; 12: 168S. (Erythropoietin in haemodialysis.)
Levenstein J. Quality of Life, symptoms and pulmonary function in asthma. A year-long multicentre double-blind trial of nedocromil sodium versus placebo. Family Pract 1991; 8: 402. (Nedocromil in asthma.)
McGauley GA, Cuneo RC, Salomon F, Sonksen PH. Psychological well-being before and after growth hormone treatment in adults with growth hormone deficiency. Hormone Res 1990; 33Suppl 4: 52. (Growth hormone treatment.)
Ringsberg KC, Wiklund I, Wilhelmsen L. Education of adult patients at an asthma school—effects on quality-of-life, knowledge and need for nursing. Eur Respirat J 1990; V3(n1): 33. (Cognitive therapy in asthma.)
Rorabeck CH, Bourne RB, Laupacis A et al. A double-blind study of 250 cases comparing cemented with cementless total hip arthroplasty. Cost-effectiveness and its impact on health-related quality of life. Clin Orthopaed 1994; 298: 156. (Hip replacement.)
Stevens P, Hodkin JE, Hopewell PC. Intermittent positive pressure breathing therapy of chronic obstructive pulmonary disease. Ann Intern Med 1983; 99: 612. (Breathing exercise in COPD.)
Weinberger M, Samsa GP, Tierney WM, Belyea MJ, Hiner SL. Generic versus disease specific health status measures: comparing the sickness impact profile and the arthritis impact measurement scales. J Rheumatol 1992; 19: 543. (Progression of hip or knee osteoarthritis.)
Wiklund I, Berg G, Hammar M, Karlberg J, Lindgren R, Sandin K. Long-term effect of transdermal hormonal therapy on aspects of quality of life in postmenopausal women. Maturitas 1992; 14: 225. (Oestrogen replacement.)
Wiklund I, Holst J, Karlberg J et al. A new methodological approach to the evaluation of QoL in postmenopausal women. Maturitas 1992; 14: 211. (Oestrogen replacement.)
Wiklund I, Karlberg J. Evaluation of quality of life in clinical trials. Selecting quality-of-life measures. Control Clin Trials 1991; 12: 204S. (Oestrogen replacement.)
Wiklund I, Karlberg J, Mattsson L. Quality of life of postmenopausal women on a regimen of transdermal estradiol therapy: a double blind placebo-controlled study. Am J Obstet Gynecol 1993; 168: 824. (Oestrogen replacement.)